Trends in management of patients with new‐onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis

In response to the evolving treatment landscape for new‐onset refractory status epilepticus (NORSE) and the publication of consensus recommendations in 2022, we conducted a comparative analysis of NORSE management over time. Seventy‐seven patients were enrolled by 32 centers, from July 2016 to Augus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epilepsia (Copenhagen) 2024-08, Vol.65 (8), p.e148-e155
Hauptverfasser: Hanin, Aurelie, Jimenez, Anthony D., Gopaul, Margaret, Asbell, Hannah, Aydemir, Seyhmus, Basha, Maysaa Merhi, Batra, Ayush, Damien, Charlotte, Day, Gregory S., Eka, Onome, Eschbach, Krista, Fatima, Safoora, Fields, Madeline C., Foreman, Brandon, Gerard, Elizabeth E., Gofton, Teneille E., Haider, Hiba A., Hantus, Stephen T., Hocker, Sara, Jongeling, Amy, Kalkach Aparicio, Mariel, Kandula, Padmaja, Kang, Peter, Kazazian, Karnig, Kellogg, Marissa A., Kim, Minjee, Lee, Jong Woo, Marcuse, Lara V., McGraw, Christopher M., Mohamed, Wazim, Orozco, Janet, Pimentel, Cederic M., Punia, Vineet, Ramirez, Alexandra M., Steriade, Claude, Struck, Aaron F., Taraschenko, Olga, Treister, Andrew K., Wainwright, Mark S., Yoo, Ji Yeoun, Zafar, Sahar, Zhou, Daniel J., Zutshi, Deepti, Gaspard, Nicolas, Hirsch, Lawrence J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!